Formycon AG (FRA:FYB)
22.80
-0.05 (-0.22%)
Last updated: Dec 3, 2025, 1:46 PM CET
Formycon AG Employees
Formycon AG had 250 employees as of December 31, 2024. The number of employees increased by 12 or 5.04% compared to the previous year.
Employees
250
Change (1Y)
12
Growth (1Y)
5.04%
Revenue / Employee
€192,296
Profits / Employee
€660,688
Market Cap
440.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 318,000 |
| Allianz SE | 156,626 |
| Deutsche Telekom AG | 198,194 |
| Siemens Energy AG | 103,000 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Rheinmetall AG | 28,539 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Formycon AG News
- 2 days ago - Formycon, MS Pharma Sign Commercialization Partnership For Keytruda Biosimilar - Nasdaq
- 2 days ago - EQS-News: Formycon and MS Pharma sign exclusive commercialization partnership for Keytruda biosimilar candidate FYB206 for the MENA Region - Wallstreet:Online
- 12 days ago - EQS-News: NTC becomes commercialization partner for Formycon’s Eylea biosimilar FYB203/Baiama in Italy - Wallstreet:Online
- 15 days ago - Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy • news - Onvista
- 16 days ago - EQS-News: Ranibizumab Biosimilar Epruvy launched in Germany - Wallstreet:Online
- 19 days ago - EQS-News: Formycon achieves key development milestone with FYB208: Biosimilar candidate for Dupixent (dupilumab) adds another growth driver to the biosimilar portfolio - Wallstreet:Online
- 20 days ago - Formycon AG 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 21 days ago - Positioning Barbados as the Caribbean's Life Sciences Hub - Benzinga